VHL and nonpapillary renal cell carcinoma: Studies have demonstrated that the pivotal molecular alteration in ccRCC is the mutation of the VHL gene, resulting in the constitutive expression of HIF, which subsequently activates multiple growth factor pathways, such as vascular endothelial growth factor (VEGF) and platelet‐derived growth factor (PDGF).2